首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1899732

胰島素幫浦市場規模、佔有率和成長分析（按類型、組件、疾病適應症、治療方法、使用類型、患者人口統計特徵、通路和地區分類）—2026-2033年行業預測

Insulin Pump Market Size, Share, and Growth Analysis, By Type, By Component, By Disease Indication, By Type of Therapy, By Usage Type, By Patient Demographics, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球胰島素幫浦市場規模將達到 60.5 億美元，到 2025 年將達到 65.5 億美元，到 2033 年將達到 123.2 億美元，預測期（2026-2033 年）的複合年成長率為 8.22%。

全球胰島素幫浦市場正經歷顯著成長，這主要得益於糖尿病（尤其是第1型糖尿病）盛行率的不斷上升以及人們對糖尿病管理意識的日益增強。攜帶式胰島素輸注系統需求的激增主要歸功於技術進步，特別是利用人工智慧（AI）和機器學習技術的智慧胰島素幫浦的研發，這些技術能夠改善患者體驗和治療效果。醫療成本的上漲和醫療服務可近性的提高也推動了先進胰島素幫浦的普及，進一步促進了該產業的擴張。隨著越來越多的患者被診斷出患有糖尿病，對有效管理方案的需求持續成長，預計胰島素幫浦市場將在這個不斷變化的醫療環境中保持強勁成長。

全球胰島素幫浦市場促進因素

全球胰島素幫浦市場正經歷顯著成長，這主要得益於製造商對創新產品研發的重視。糖尿病患者對胰島素幫浦的接受度不斷提高，無論是在已開發國家還是開發中國家，都是推動這一趨勢的關鍵因素。此外，多項臨床試驗表明，與每日多次注射（MDI）療法相比，胰島素幫浦療法能夠顯著改善第二型糖尿病患者的血糖控制。這些改善患者預後的證據激勵各公司進一步改進產品，並拓展產品線，以滿足日益成長的先進糖尿病管理解決方案的需求。

全球胰島素幫浦市場限制因素

全球胰島素幫浦市場成長受多種因素制約，其中最主要的是病患對健保報銷體系的依賴。許多患者面臨健保報銷選擇有限和胰島素幫浦高成本，這成為他們接受治療的障礙。這些經濟障礙不僅影響那些尋求有效管理自身健康狀況的患者，也可能減緩整個市場的擴張。因此，消除這些經濟障礙對於改善患者獲得胰島素幫浦的途徑以及推動產業成長至關重要。

全球胰島素幫浦市場趨勢

全球胰島素幫浦市場正經歷一場重大變革，其驅動力在於智慧技術（尤其是人工智慧 (AI)）的融合，旨在提升糖尿病管理的效率。糖尿病盛行率的不斷攀升，推動了對能夠實現治療方案自動化和個人化的先進胰島素輸注系統的需求。醫療設備製造商正大力投資於人工智慧賦能的胰島素泵，以期改善患者的治療效果，並推動智慧醫療解決方案的轉型。這一成長表明，2 型糖尿病患者對胰島素幫浦的接受度正在不斷提高，這將進一步促進醫療資訊科技領域的市場成長和創新。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic
Tandem Diabetes Care
Insulet Corporation
Ypsomed
Roche Diabetes Care
Beta Bionics Inc.
Medtrum Technologies
B. Braun Melsungen AG
Sooil Development Co. Ltd.
Sequel Med Tech, LLC
Jiangsu Delfu Co., Ltd.
ViCentra BV
MicroTech Medical
PharmaSens
Microport Scientific
Debiotech SA

結論與建議

簡介目錄

Product Code: SQMIG35A2135

Global Insulin Pump Market size was valued at USD 6.05 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 12.32 Billion by 2033, growing at a CAGR of 8.22% during the forecast period (2026-2033).

The global Insulin Pump Market is experiencing significant growth driven by the increasing prevalence of diabetes, especially type 1 diabetes, and a heightened awareness of diabetes management. This surge in demand for portable insulin delivery systems is largely attributed to advancements in technology, particularly the development of smart pumps utilizing artificial intelligence and machine learning, which enhance patient experience and treatment efficacy. The industry's expansion is further supported by rising healthcare expenditures and improved access to medical facilities, making sophisticated insulin pumps more widely available. As more individuals are diagnosed with diabetes, the need for effective management solutions continues to rise, positioning the Insulin Pump Market for robust growth in response to these evolving healthcare dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segments Analysis

Global Insulin Pumps Market is segmented by Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel and region. Based on Type, the market is segmented into Tethered Insulin Pumps, Patch Pumps (Tubeless Pumps), Miniature/Implantable Pumps and Smart Insulin Pumps. Based on Component, the market is segmented into Pump Device, Infusion Set (Cannula & Tubing), Reservoir or Cartridge, Battery and Power Systems and Control System & Software. Based on Disease Indication, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on Type of Therapy, the market is segmented into Conventional Insulin Therapy, Continuous Subcutaneous Insulin Infusion (CSII), Automated Insulin Delivery (AID) or Closed Loop Systems and Hybrid Closed Loop Systems. Based on Usage Type, the market is segmented into Reusable Insulin Pumps and Disposable Insulin Pumps. Based on Patient Demographics, the market is segmented into Pediatric (0-17 years), Adult (18+ years) and Geriatric (65+ years). Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Direct Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pump Market

The Global Insulin Pump market is experiencing significant growth, driven by manufacturers' focus on research and development of innovative products. The increasing acceptance of insulin pumps among diabetic patients in both advanced and developing regions is a key factor propelling this trend. Additionally, various clinical trials have demonstrated notable enhancements in glucose management for type 2 diabetes patients using pump therapy compared to those relying on Multiple Daily Injection (MDI) therapy. This evidence of improved patient outcomes is further motivating companies to refine their offerings and expand their product lines to meet the rising demand for advanced diabetes management solutions.

Restraints in the Global Insulin Pump Market

The growth of the global insulin pump market is hampered by several factors, particularly the reliance on reimbursements for treatment accessibility. Many patients face challenges due to limited reimbursement options and the high costs associated with insulin pumps, which can discourage their adoption. This financial barrier not only affects individuals seeking effective management of their health conditions but may also contribute to a slower overall market expansion. As a result, addressing these economic obstacles is crucial for enhancing patient access to insulin pumps and fostering growth within the industry.

Market Trends of the Global Insulin Pump Market

The global insulin pump market is experiencing a significant transformation driven by the integration of intelligent technologies, particularly artificial intelligence, which enhances diabetes management efficiencies. As diabetes prevalence rises, there is an emerging demand for advanced insulin delivery systems that offer automation and personalization in treatment regimens. Device manufacturers are strategically investing in AI-enabled pumps to facilitate improved patient outcomes, fostering a shift towards smart healthcare solutions. This growing trend signals an increased adoption of insulin pumps among individuals with type 2 diabetes, further propelling market growth and innovation within the healthcare IT landscape.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Insulin Pump Market Size by Type & CAGR (2026-2033)

Market Overview
Tethered Insulin Pumps
Patch Pumps (Tubeless Pumps)
Miniature/Implantable Pumps
Smart Insulin Pumps

Global Insulin Pump Market Size by Component & CAGR (2026-2033)

Market Overview
Pump Device
Infusion Set (Cannula & Tubing)
Reservoir or Cartridge
Battery and Power Systems
Control System & Software (Apps/Monitors)

Global Insulin Pump Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Type 1 Diabetes
Type 2 Diabetes

Global Insulin Pump Market Size by Type of Therapy & CAGR (2026-2033)

Market Overview
Conventional Insulin Therapy
Continuous Subcutaneous Insulin Infusion (CSII)
Automated Insulin Delivery (AID) or Closed Loop Systems
Hybrid Closed Loop Systems

Global Insulin Pump Market Size by Usage Type & CAGR (2026-2033)

Market Overview
Reusable Insulin Pumps
Disposable Insulin Pumps

Global Insulin Pump Market Size by Patient Demographics & CAGR (2026-2033)

Market Overview
Pediatric (0-17 Years)
Adult (18+ Years)
Geriatric (65+ Years)

Global Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Direct Sales

Global Insulin Pump Market Size & CAGR (2026-2033)

North America (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- US
- Canada
Europe (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beta Bionics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtrum Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sooil Development Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sequel Med Tech, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViCentra B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroTech Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmaSens
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microport Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Debiotech S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments